Pulse oximetry motion artifact rejection using near infrared absorption by water
View Patent ↗A method and an apparatus for measuring a physiological parameter, functioning based on obtaining a first signal derived from electromagnetic energy transmitted through a tissue portion at a first wavelength, the first signal including a signal portion corresponding with motion-related events and a signal portion corresponding with arterial pulsation events, where at the first wavelength water is a dominant absorber of electromagnetic energy in the tissue portion; obtaining a second signal derived from electromagnetic energy transmitted through a tissue portion at a second wavelength, the second signal including a signal portion corresponding with motion-related events and a signal portion corresponding with arterial pulsation events, where at the second wavelength hemoglobin is a dominant absorber of electromagnetic energy in the tissue portion; and combining the first signal and the second signal to generate a combined plethysmograph signal, such that the combined signal has a signal portion corresponding with motion-related events that is smaller than that present in the first signal or the second signal.
1. A method of measuring a physiological parameter, comprising:
obtaining a first signal corresponding to a first wavelength of light passing through a tissue, wherein the first wavelength is in the near infrared region of the spectrum, and wherein light at the first wavelength is primarily absorbed by hemoglobin;
obtaining a second signal corresponding to a second wavelength of light passing through the tissue, wherein the second wavelength is in the near infrared region of the spectrum, and wherein light at the second wavelength is primarily absorbed by hemoglobin;
obtaining a third signal corresponding to a third wavelength of light passing through the tissue, wherein the third wavelength is in the near infrared region of the spectrum, and wherein light at the third wavelength is primarily absorbed by water; and
determining a value for oxygen saturation of the tissue based on the first signal and the second signal by utilizing the third signal for noise correction.
2. The method of claim 1 , wherein the first wavelength and the second wavelength are between about 800 nm and 1100 nm.
3. The method of claim 2 , wherein the first wavelength is about 940 nm and wherein the second wavelength is about 1040 nm.
4. A method of measuring a physiological parameter, comprising:
obtaining a first signal corresponding to a first wavelength of light passing through a tissue, wherein the first wavelength is in the near infrared region of the spectrum, and wherein light at the first wavelength is primarily absorbed by hemoglobin;
obtaining a second signal corresponding to a second wavelength of light passing through the tissue, wherein the second wavelength is in the near infrared region of the spectrum, and wherein light at the second wavelength is primarily absorbed by hemoglobin;
obtaining a third signal corresponding to a third wavelength of light passing through the tissue, wherein the third wavelength is in the near infrared region of the spectrum, and wherein light at the third wavelength is primarily absorbed by water;
combining the first signal with the third signal to obtain a first noise-corrected signal;
combining the second signal with the third signal to obtain a second noise-corrected signal; and
determining a value for oxygen saturation of the tissue based on the first noise-corrected signal and the second noise-corrected signal.
5. The method of claim 4 , wherein the first wavelength and the second wavelength are between about 800 nm and 1100 nm.
6. The method of claim 5 , wherein the first wavelength is about 940 nm and wherein the second wavelength is about 1040 nm.
7. The method of claim 4 , wherein the third wavelength is between about 1100 nm and 1400 nm.
8. The method of claim 7 , wherein the third wavelength is about 1180 nm.
9. A pulse oximeter comprising:
a processor configured to determine a value for oxygen saturation of a tissue from a first signal, a second signal, and a third signal, wherein the first signal corresponds to a first wavelength of light passing through the tissue, the second signal corresponds to a second wavelength of light passing through the tissue, and the third signal corresponds to a third wavelength of light passing through the tissue, and wherein the first wavelength and the second wavelength are in the near infrared region of the spectrum and primarily absorbed by hemoglobin in the tissue and the third wavelength is in the near infrared region of the spectrum and primarily absorbed by water in the tissue, and the processor is configured to determine the value for oxygen saturation of the tissue based on the first signal and the second signal by utilizing the third signal for noise correction.
10. The pulse oximeter of claim 9 , wherein the first wavelength and the second wavelength are between about 800 nm and 1100 nm.
11. The pulse oximeter of claim 10 , wherein the first wavelength is about 940 nm and wherein the second wavelength is about 1040 nm.
12. A pulse oximeter comprising:
a processor configured to determine a value for oxygen saturation of a tissue from a first signal, a second signal, and a third signal, wherein the first signal corresponds to a first wavelength of light passing through the tissue, the second signal corresponds to a second wavelength of light passing through the tissue, and the third signal corresponds to a third wavelength of light passing through the tissue, and wherein the first wavelength and the second wavelength are in the near infrared region of the spectrum and primarily absorbed by hemoglobin in the tissue and the third wavelength is in the near infrared region of the spectrum and primarily absorbed by water in the tissue, and the processor is configured to combine the first signal with the third signal to obtain a first noise-corrected signal, combine the second signal with the third signal to obtain a second noise-corrected signal, and determine the value for oxygen saturation of the tissue based on the first noise-corrected signal and the second noise-corrected signal.
13. The pulse oximeter of claim 12 , wherein the first wavelength and the second wavelength are between about 800 nm and 1100 nm.
14. The pulse oximeter of claim 13 wherein the first wavelength is about 940 nm and wherein the second wavelength is about 1040 nm.
15. The pulse oximeter of claim 12 , wherein the third wavelength is between about 1100 nm and 1400 nm.
16. The pulse oximeter of claim 15 , wherein the third wavelength is about 1180 nm.